Hyperlipidemia

Audience: Patients and providers
Status: Clinical guide · patient + provider
Last updated: 2026-03-09

1. Clinical overview

Hyperlipidemia refers to elevated atherogenic lipoproteins that increase ASCVD risk over time, making treatment decisions heavily dependent on baseline risk, LDL burden, and secondary causes.

2. Common causes and risk factors

Elevated atherogenic lipoproteins from genetics, insulin resistance, diet, and sedentary patterns.
Secondary contributors: hypothyroidism, nephrotic syndrome, medication effects.

3. Typical symptoms

Usually asymptomatic; concern is long-term ASCVD risk.

4. Diagnosis and evaluation

Confirm diagnosis with guideline-based history, exam, and indicated testing.
Screen for severity, complications, and high-risk comorbid conditions.
Identify social or access barriers that could affect treatment success.

5. Treatment (non-pharmacologic)

Mediterranean-style or similar cardioprotective dietary pattern.
Exercise, weight reduction, and tobacco cessation.
Shared decision-making using absolute risk and patient priorities.

6. Treatment (pharmacologic)

Statin therapy commonly uses atorvastatin or rosuvastatin for high-intensity treatment and pravastatin or simvastatin in selected lower-intensity scenarios.
Ezetimibe is the usual next add-on when LDL remains above threshold; PCSK9-pathway agents include evolocumab, alirocumab, and inclisiran in selected patients.
Severe hypertriglyceridemia may require fenofibrate, prescription omega-3 therapy, or tighter secondary-cause management to reduce pancreatitis risk.

7. Monitoring and follow-up

Lipid panel response, adherence, muscle symptoms, and liver labs when indicated.

8. Practical counseling points

Give patients a clear “what to do today / when to call / when to seek urgent care” plan.
Use teach-back to confirm understanding of treatment goals and medication instructions.
Simplify regimens when possible to improve adherence and outcomes.

9. Red flags and escalation

Escalate care urgently for severe or rapidly worsening symptoms.
Reassess diagnosis if expected response does not occur within the anticipated timeline.

10. Guideline references

Note: Educational guide only; not a substitute for individualized medical care.